EUVIMEDEUVIMED entdecken
Crossref

Colchicine Inhibits Smooth Muscle Cell Phenotypic Switch and Aortic Dissection in Mice—Brief Report

Hui Jiang iD, Yaping Zhao iD, Mei Jin, Zhidan Zhang, Li Wang iD, Xiang Cheng iD, Yu Huang iD, Zhiping Liu iD, Jianping Weng, Suowen Xu iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025

DOI: 10.1161/atvbaha.124.322252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Hui Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sc…. Hauptthemen laut MEDLINE: Colchicine, Aortic Dissection, Muscle, Smooth, Vascular, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Aortic dissection (AD) is a severe cardiovascular disorder characterized by intimal tearing and subsequent delamination of the aortic wall. The pathogenesis of AD primarily involves the phenotypic switch of vascular smooth muscle cells (VSMCs), degradation of the extracellular matrix, and chronic vascular inflammation. Colchicine, an alkaloid derived from Colchicum autumnale L , is a Food and Drug Administration–approved anti-inflammatory drug with established therapeutic applications in cardiovascular diseases. However, its potential role in modulating the development or progression of AD remains largely unexplored. METHODS: To investigate the effects of colchicine on AD, a β-aminopropionitrile–induced AD mouse model was used. Colchicine was administered via oral gavage over a 3-week period to evaluate its impact on the incidence and mortality of AD in male C57BL/6J mice. Transcriptome sequencing was performed to identify genes and signaling pathways regulated by colchicine. Additionally, in vitro experiments using primary rat VSMCs were conducted to elucidate the mechanisms underlying colchicine-mediated regulation of VSMC phenotypic switch. RESULTS: Colchicine demonstrated a protective effect against AD by attenuating vascular inflammation and suppressing VSMC phenotypic switch. Mechanistically, colchicine reverses VSMC phenotypic switch at least partially by modulating the expression of myocardin, a key regulator of VSMC contractile phenotype. Transcriptomic analysis further revealed specific genes and pathways influenced by colchicine, providing insights into its molecular mechanisms of action. CONCLUSIONS: This study identifies colchicine as a potential therapeutic drug for AD, highlighting its ability to mitigate hallmark pathological processes such as vascular inflammation and VSMC phenotypic switch. These findings offer a foundation base for the repurposed clinical application of colchicine in AD, which warrants further clinical investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineAortic DissectionMuscle, Smooth, VascularMyocytes, Smooth MuscleAortic AneurysmAnti-Inflammatory AgentsAnimalsMice, Inbred C57BLMalePhenotypeDisease Models, AnimalMiceCells, CulturedTrans-ActivatorsRatsNuclear ProteinsSignal TransductionAminopropionitrileMyocardin

Stichwörter der Autor:innen

aortic dissectioncolchicineinflammationmyocardin

Substanzen

ColchicineTrans-ActivatorsNuclear ProteinsAminopropionitrileAnti-Inflammatory AgentsMyocardin

Autor:innen und Institutionen

  • Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, He…
  • Department of Cardiothoracic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei (H.J.).
  • Department of Biomedical Sciences, City University of Hong Kong, China (Y.Z., L.W., Y.H.).
  • State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou,…
  • Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China (X.C.).
  • Anhui Provincial Key Laboratory of Metabolic Health and Panvascular Diseases, Hefei, China (J.W., S.X.).

ORCID-Profile: Hui Jiang, Yaping Zhao, Li Wang, Xiang Cheng, Yu Huang, Zhiping Liu, Suowen Xu

Zitieren

APA

Jiang, H., Zhao, Y., Jin, M., Zhang, Z., Wang, L., Cheng, X., Huang, Y., Liu, Z., Weng, J., & Xu, S. (2025). Colchicine Inhibits Smooth Muscle Cell Phenotypic Switch and Aortic Dissection in Mice—Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.322252

Vancouver

Jiang H, Zhao Y, Jin M, Zhang Z, Wang L, Cheng X, et al. Colchicine Inhibits Smooth Muscle Cell Phenotypic Switch and Aortic Dissection in Mice—Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.124.322252

BibTeX
@article{Jiang2025,
  author = {Jiang, Hui and Zhao, Yaping and Jin, Mei and Zhang, Zhidan and Wang, Li and Cheng, Xiang and Huang, Yu and Liu, Zhiping and Weng, Jianping and Xu, Suowen},
  title = {Colchicine Inhibits Smooth Muscle Cell Phenotypic Switch and Aortic Dissection in Mice—Brief Report},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  doi = {10.1161/atvbaha.124.322252}
}
Kostenlos starten →